New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

Adults with plaque psoriasis aged 65 years and older had similar responses to IL-17 and IL-23 inhibitors to that of younger adults.

While actives like vitamin C, kojic acid, niacinamide, and alpha arbutin do work, they’re a double-edged sword.

A retrospective analysis of US medical records of people aged 65-95 years finds those with psoriasis on systemic therapies ...

Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according ...

Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.

Discover a study in which researchers examined three international cohorts of patients with moderate-to-severe psoriasis ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...

8% of patients maintained that the ongoing war had affected the quality of the treatment they are receiving for psoriasis.

People with darker skin still need to wear sunscreen — for more reasons than one. Too much ultraviolet exposure from the sun can lead to sunburn, dark spots and wrinkles, and increased risk of skin ...

If you have psoriasis, you may feel like this autoimmune ... a dermatologic surgeon, and a healthy skin advocate. Her practice philosophy focuses on patient education, with a holistic approach ...

NOW the sun is out, your SPF should be too. Did you know we are recommended to use two shot glasses worth of suncream to cover our body? It might seem excessive, but no patch should be left ...